Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

If you liked this article you might like

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

Biotech movers: CEL-SCI Leaps After FDA Lets Cancer Study Move Forward

Roche Lifts Full-Year Outlook After Solid Q2 Earnings Beat

China Was Right to Walk Away From Failed U.S. Trade Talks

Roche Expands Into App-Based Digital Health With mySugr Deal